Tirzepatide 10MG

Product Specifications

• CAS Number: 2023788-19-2
• Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
• Molecular Weight: 4813.45 g/mol
• Purity: >99%+ (HPLC verified)
• Form: Lyophilized powder
• Quantity: 10mg per vial

Research Summary

Tirzepatide is a synthetic peptide that acts as a dual agonist at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. In-vitro binding assays have demonstrated that tirzepatide exhibits high affinity for both the GIP and GLP-1 receptors, with a relative preference for GIP receptor activation. This dual mechanism of action has been investigated in preclinical models for its effects on incretin signaling pathways and glucose homeostasis.

In animal models, tirzepatide has been studied for its influence on pancreatic islet cell function, including glucose-dependent insulin secretion and glucagon suppression pathways. Preclinical research in rodent models has examined its effects on central metabolic signaling circuits, hepatic lipogenesis markers, and adipose tissue remodeling. The compound’s C-20 fatty diacid moiety has been investigated for its role in extending pharmacokinetic duration through albumin binding in animal studies.

Researchers have utilized tirzepatide as a tool compound for exploring the synergistic effects of simultaneous GIP and GLP-1 receptor activation versus single-receptor agonism in metabolic pathway research. Preclinical studies have also investigated its effects on inflammatory biomarkers, lipid metabolism gene expression, and mitochondrial function in various tissue models.

Storage

Store lyophilized peptide at -20°C. Reconstituted solution should be stored at 2-8°C and used within 30 days. Avoid repeated freeze-thaw cycles.

Shipping

Ships same-day from our Canadian facility. All orders include temperature-controlled packaging.

For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.

Related Research Articles

Learn more about this compound through our peer-reviewed research summaries:

• GLP-1 Receptor Agonist Research Pharmacology